LOS ANGELES CAPITAL MANAGEMENT LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2021$505,000
-37.5%
18,005
-42.0%
0.00%
-33.3%
Q4 2020$808,000
-30.1%
31,067
-0.1%
0.00%
-40.0%
Q3 2020$1,156,000
-27.5%
31,0920.0%0.01%
-37.5%
Q2 2020$1,595,000
+61.6%
31,092
-0.7%
0.01%
+33.3%
Q1 2020$987,000
-59.0%
31,317
-22.5%
0.01%
-50.0%
Q4 2019$2,408,000
+40.7%
40,385
-13.5%
0.01%
+33.3%
Q3 2019$1,712,000
+33.8%
46,690
+69.7%
0.01%
+28.6%
Q2 2019$1,280,000
+459.0%
27,520
+770.9%
0.01%
+600.0%
Q1 2018$229,0003,1600.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders